CAI
LLY icon

Capital Advisors Inc’s Eli Lilly LLY Stock Holding History

Capital Advisors Inc’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.54M Buy
6,287
+138
+2% +$141K 0.11% 101
2026
Q1 		$5.66M Sell
6,149
-74
-1% -$75K 0.09% 101
2025
Q4 		$6.69M Buy
6,223
+398
+7% +$381K 0.11% 100
2025
Q3 		$4.44M Sell
5,825
-922
-14% -$686K 0.07% 100
2025
Q2 		$5.26M Buy
6,747
+429
+7% +$333K 0.09% 96
2025
Q1 		$5.22M Buy
6,318
+892
+16% +$742K 0.1% 95
2024
Q4 		$4.19M Sell
5,426
-261
-5% -$216K 0.08% 101
2024
Q3 		$5.04M Buy
5,687
+1,141
+25% +$1.03M 0.1% 96
2024
Q2 		$4.12M Buy
4,546
+127
+3% +$102K 0.09% 102
2024
Q1 		$3.44M Buy
4,419
+466
+12% +$332K 0.07% 108
2023
Q4 		$2.3M Buy
3,953
+567
+17% +$331K 0.05% 126
2023
Q3 		$1.82M Buy
3,386
+108
+3% +$55.7K 0.05% 107
2023
Q2 		$1.54M Buy
3,278
+412
+14% +$173K 0.04% 119
2023
Q1 		$984K Buy
2,866
+73
+3% +$24.6K 0.03% 134
2022
Q4 		$1.02M Buy
2,793
+66
+2% +$23.4K 0.03% 132
2022
Q3 		$904K Sell
2,727
-20
-0.7% -$6.34K 0.03% 131
2022
Q2 		$891K Buy
2,747
+20
+0.7% +$6K 0.03% 138
2022
Q1 		$781K Buy
2,727
+81
+3% +$20.8K 0.02% 140
2021
Q4 		$731K Sell
2,646
-102
-4% -$25.9K 0.02% 143
2021
Q3 		$635K Sell
2,748
-199
-7% -$49.1K 0.02% 147
2021
Q2 		$676K Buy
2,947
+379
+15% +$76.1K 0.02% 146
2021
Q1 		$480K Sell
2,568
-117
-4% -$22.9K 0.02% 162
2020
Q4 		$453K Buy
2,685
+1,200
+81% +$179K 0.02% 141
2020
Q3 		$220K Buy
1,485
+82
+6% +$12.7K 0.01% 178
2020
Q2 		$214K Buy
+1,403
New +$215K 0.01% 169
2019
Q1 		– Sell
-2,677
Closed -$310K – 159
2018
Q4 		$310K Buy
2,677
+400
+18% +$44.7K 0.02% 151
2018
Q3 		$244K Sell
2,277
-1,000
-31% -$100K 0.01% 163
2018
Q2 		$280K Hold
3,277
– – 0.02% 154
2018
Q1 		$254K Hold
3,277
– – 0.02% 164
2017
Q4 		$277K Hold
3,277
– – 0.02% 170
2017
Q3 		$280K Sell
3,277
-231
-7% -$18.9K 0.02% 159
2017
Q2 		$289K Sell
3,508
-203
-5% -$16.6K 0.02% 165
2017
Q1 		$312K Buy
3,711
+820
+28% +$65.7K 0.02% 154
2016
Q4 		$213K Hold
2,891
– – 0.01% 168
2016
Q3 		$232K Buy
2,891
+167
+6% +$13.4K 0.03% 112
2016
Q2 		$215K Buy
+2,724
New +$205K 0.03% 116
2016
Q1 		– Sell
-2,745
Closed -$231K – 135
2015
Q4 		$231K Buy
2,745
+268
+11% +$22.2K 0.04% 109
2015
Q3 		$207K Buy
+2,477
New +$209K 0.04% 112

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Capital Advisors Inc's LLY Position: Q2 2026 in Review

Capital Advisors Inc increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $141K and bringing the position to 6,287 shares worth $7.54M. The position accounts for 0.11% of the portfolio, ranked #101.

Capital Advisors Inc first reported a position in LLY in Q3 2015 and has held it in 38 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital Advisors Inc held 6,287 shares of Eli Lilly worth $7.54M as of Q2 2026.
  • Capital Advisors Inc bought 138 Eli Lilly shares in Q2 2026, an estimated $141K.
  • Eli Lilly made up 0.11% of Capital Advisors Inc's portfolio in Q2 2026, its #101 holding.
  • Capital Advisors Inc first reported a position in Eli Lilly in Q3 2015 and has held it in 38 quarters since.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.